
1. Technology overview
OncoSoft Inc. is a radiation therapy software company established in September 2019, headquartered in Seodaemun-gu, Seoul, South Korea, with a US office in Southlake, Texas. It builds AI tools that shorten the planning workflow for radiation oncology departments.
OncoStudio is an AI auto-contouring solution that segments more than 190 normal organs and clinical target volumes from CT and MR images, with support for DICOM and HL7 FHIR. The company also lists OncoFlow for radiotherapy workflow management. It is sold to hospitals and through distributors such as Anzai Medical in Japan.
2. Highlighted features & specifications
- Auto-contouring: AI segmentation of more than 190 normal organs and clinical target volumes.
- Multi-modality input: CT and MR images, with CBCT and MVCT models listed for later.
- OncoFlow: workflow management for radiotherapy departments.
- Interoperability: DICOM and HL7 FHIR support.
- Roadmap: OncoPlan treatment planning and OncoRPT workflow management in progress.
3. Potential application
Radiation oncology departments in Vietnamese cancer hospitals can use OncoStudio to speed up treatment planning. Private cancer centers adding linear accelerators can pair it with their planning system. Teaching hospitals can use it for contouring standardization in training.
4. Benefits
- Automates organ and target contouring that is otherwise manual and time-consuming.
- Works with standard hospital formats (DICOM, HL7 FHIR).
- Holds FDA 510(k), Korean MFDS, Japan, Singapore HSA and Brazil ANVISA clearances.
- Certified to ISO 13485 and ISO/IEC 27001 and 27701.
5. Market trends & opportunities
Radiotherapy centers face heavy contouring workloads and clinician shortages, and AI auto-segmentation is becoming a standard part of planning workflows. Regulatory registration in Singapore in 2025 shows the vendor is targeting Southeast Asian hospitals, relevant to growing cancer centers in Vietnam.
6. Other information
Founded September 2019, Seoul. Series B KRW 11 billion in September 2024. Mayo Clinic supply agreement (March 2025), AWS business arrangement (October 2024), distribution with Anzai Medical (Japan). FDA 510(k) in February 2025.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
RETAIL E-COMMERCE: AI AND REAL-TIME DATA ARE TRANSFORMING HOW RETAIL BUSINESSES OPERATE








































